April 19th 2021October 25th 2020 How an executive MBA was the catalyst for a pharma start-up Read more at: https://www.ft.com/content/47e44547-a815-4d1c-a980-7581268343ba
FDA Approves Tepylute for Breast and Ovarian Cancer TreatmentJuly 2nd 2024Read More FDA Approves Tepylute for Breast and Ovarian Cancer Treatment
FDA approves Shorla Oncology’s TEPYLUTE for cancer treatmentJuly 2nd 2024Read More FDA approves Shorla Oncology’s TEPYLUTE for cancer treatment
Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian CancerJuly 2nd 2024Read More Shorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian Cancer